The takeaways i got from the last discussion with bio was that...

The takeaways i got from the last discussion with bio was that they seem to have re formed and are heading in a better direction. That being said i must admit i wasnt fully aware of the fact that firstly no cpp is currently approved for use. Secondly the discussion on the sink effect of cpp in human medicine ie they can hit something hard and trials might look good in mouse model but that doesnt reflect human equivalent. That does explain why they were injecting tumors rather than iv application and in human model why blood cancer makes more sense. None of that would have come from pyc updates though i guess cos they just give the positive spin.

The concern then is that they were apparently unaware of this and when they realised that was why they changed target from breast cancer to blood bourne cancer. On the plus side they are adaptable and not afraid to move on, but on the negative side this makes it look like they have a technology and are desperately trying to find a use for it. I enjoy having discussions on the technology but the apparent lack of interest in any discussion that wasnt pumping up the tyres made me give up, to many proples joy im sure.